Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
Eichhorst, Barbara F
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. [electronic resource] - British journal of haematology Jan 2007 - 63-72 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0007-1048
10.1111/j.1365-2141.2006.06382.x doi
Anti-Infective Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chi-Square Distribution
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Leukopenia
Male
Middle Aged
Multivariate Analysis
Remission Induction
Respiratory Tract Infections--drug therapy
Risk Factors
Survival Rate
Vidarabine--administration & dosage
Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy. [electronic resource] - British journal of haematology Jan 2007 - 63-72 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0007-1048
10.1111/j.1365-2141.2006.06382.x doi
Anti-Infective Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chi-Square Distribution
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Leukopenia
Male
Middle Aged
Multivariate Analysis
Remission Induction
Respiratory Tract Infections--drug therapy
Risk Factors
Survival Rate
Vidarabine--administration & dosage